American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) shared a post on LinkedIn:
“The ACS NLCRT Lung Cancer Biomarker Testing ECHO – Cohort 5 is already underway, and there’s still time to join the remaining sessions!
Designed for physicians – medical oncologists, pathologists, patient navigators, and thoracic surgeons and radiation oncologists, this series helps teams overcome barriers to NSCLC biomarker testing and bring actionable solutions back to their institutions. Participants will learn from national experts, explore best practices for comprehensive testing, improve access to guideline-concordant care, and connect with multidisciplinary clinical leaders.
The remaining three monthly, hour-long sessions run January – March 2026. Register here.”
More posts featuring ACS NLCRT on OncoDaily.
